Spectrum Pharmaceuticals Announces Promising Clinical Data for ZEVALIN(R) and …MarketWatch (press release)A Phase 2 investigator-sponsored study in patients with stage III/IV CD20+ DLBCL (Abstract # 6633) found that short-duration therapy consisting …
Kidney transplant drug boosts immune activity in breast cancerOncology Nurse AdvisorThe immunosuppressant agent daclizumab, which is used to prevent acute organ rejection in persons undergoing renal transplants, has now been shown to improve survival b…
SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits …SYS-CON Media (press release)Come to New York and get yourself up to date with the Big Data revolution! As advanced data storage, access and analytics technologies aimed at…
SymBio Announces Results Presented at ASCO 2012 Evaluating …Marketwire (press release)SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits of TREAKISYM® (Bendamustine) in Combination With Rituximab in Patients …
SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits …MarketWatch (press release)TOKYO, Jun 04, 2012 (MARKETWIRE via COMTEX) — SymBio Pharmaceuticals Limited (jasdaq:4582) announced today that results from a multicenter, Phas…
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI …MarketWatch (press release)Abstract # 6515: Combination of the Bruton's tyrosine kinase inhibitor PCI-32765 with bendamustine/rituximab (BR) in patients with relapsed/ref…
'Rediscovered' lymphoma drug helps double survival: studyMedical XpressThe drug, bendamustine, more than doubled disease progression-free survival when given along with another therapy, rituximab (Rituxan), compared to the drug cocktail that…
From Earlier: Results from a Randomized Study of REVLIMID and Rituximab in …BenzingaCelgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG), announced results from a randomized study comparing REVLIMID® (lenalidomide) plus ri…
'Rediscovered' Lymphoma Drug Helps Double Survival: StudyU.S. News & World ReportThe drug, bendamustine, more than doubled disease progression-free survival when given along with another therapy, rituximab (Rituxan), compared to the drug cockta…
ASCO: Treanda Combo Works in Indolent LymphomasMedPage TodayNote that the bendamustine-rituximab combination had significantly lower rates of a range of adverse events, including hair loss, leukocytopenia, neutropenia, and paresthesias compared with st…